8-K: Semler Scientific & Strive Merger: Pro Forma Financials Released

Semler Scientific files supplemental unaudited pro forma financials for its all-stock acquisition by Strive, Inc., detailing combined financial outlook.

Summary

• Semler Scientific, Inc. (SMLR) has filed supplemental unaudited pro forma combined consolidated financial information regarding its previously announced all-stock acquisition by Strive, Inc. (ASST).
• The merger agreement, dated September 22, 2025, stipulates that each share of Semler common stock will be converted into the right to receive 21.05 shares of Strive Class A common stock.
• Strive is deemed the accounting acquirer, with its historical financial statements forming the basis of the combined entity, and Semler Scientific's identifiable assets and liabilities recognized at fair value as of the transaction date.
• The pro forma financials include a combined balance sheet as of September 30, 2025, and combined statements of operations for the nine months ended September 30, 2025, and the year ended December 31, 2024.
• The pro forma combined entity reported a net loss of $200,145 thousand for the nine months ended September 30, 2025, compared to a net income of $9,205 thousand for the year ended December 31, 2024.
• Estimated purchase price consideration for Semler Scientific is approximately $471.7 million, based on 318,743,205 shares of Strive Class A common stock valued at $1.48 per share.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the significant pro forma net loss reported for the nine months ended September 30, 2025, and the explicit mention of numerous risks associated with the merger and Bitcoin treasury strategy. While the merger is progressing, the immediate financial outlook presented is challenging.

Positives

• The filing indicates the merger process is progressing with the release of supplemental pro forma financial information.
• The pro forma combined entity shows a net income of $9,205 thousand for the year ended December 31, 2024, prior to the significant transaction costs impacting the later period.

Negatives

• The pro forma combined entity reported a significant net loss of $200,145 thousand for the nine months ended September 30, 2025.
• Transaction costs related to the Semler Merger are substantial, totaling $23,201 thousand for the nine months ended September 30, 2025, and an additional $10,114 thousand for the year ended December 31, 2024 (as a pro forma adjustment).
• The pro forma basic and diluted earnings per common share for the nine months ended September 30, 2025, show a loss of $(0.43).

Risks

• Risks related to volatility in Bitcoin and Semler Scientific's Bitcoin treasury strategy and healthcare business.
• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both parties to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The filing includes forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific with respect to the proposed transaction, including anticipated strategic and financial benefits, the timing of closing, and the ability to successfully integrate the combined businesses. However, it also highlights numerous risks that could cause actual results to differ materially from anticipated results, particularly concerning Bitcoin volatility and integration challenges.

Management Comments

• Strive's senior management is expected to control the strategic direction of Strive following consummation of the Semler Merger.
• Strive's designated leadership will control the combined entity's operations post business combination.
• Strive's existing directors will control the majority of the post business combination board.

Industry Context

This merger combines Semler Scientific, a healthcare company that has adopted a Bitcoin treasury strategy, with Strive, a bitcoin treasury asset management firm. This unusual combination suggests a strategic pivot or diversification for Semler Scientific into digital assets, or Strive's expansion into healthcare, potentially leveraging Semler's existing business while integrating a significant Bitcoin treasury component. This reflects a broader, albeit niche, trend where companies are exploring Bitcoin as a treasury asset, even those outside the traditional financial sector.

Management Changes

Corporate Governance

Legal Proceedings

• The filing mentions 'the outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company' as a potential risk factor, but does not detail any specific ongoing proceedings.

Stakeholder Impact

• Shareholders (Semler Scientific): Will receive 21.05 shares of Strive Class A common stock for each Semler share, leading to dilution in the combined entity and a shift in ownership structure.
• Shareholders (Strive): Will retain the majority voting and economic interest in the combined entity, but will experience dilution from the issuance of new shares to Semler stockholders.
• Customers: Potential adverse reactions or changes to business relationships are listed as a risk due to the merger announcement or completion.
• Employees: Potential adverse reactions or changes to employee relationships are listed as a risk due to the merger announcement or completion.
• Creditors: The combined entity's financial position, including a significant pro forma net loss for the recent period, could impact credit perception and future borrowing terms.

Next Steps

• Completion of the acquisition method of accounting, including final purchase price allocation and valuation analysis.
• Strive to file a definitive Information Statement/Proxy Statement/Prospectus with the SEC.
• Semler Scientific stockholders to vote on the proposed transaction.
• Satisfaction or waiver of customary closing conditions for the merger.
• Integration of the combined businesses post-closing.

Key Dates

Recommendation

The filing provides preliminary pro forma financial information for a pending merger, which is a significant corporate event. While the pro forma results for the most recent nine-month period show a substantial loss, this is preliminary and subject to final accounting. The strategic rationale for combining a healthcare company with a Bitcoin treasury firm is unusual and carries inherent risks, particularly related to Bitcoin volatility and integration challenges. Investors should hold to observe the actual closing of the merger, the final financial reporting, and the combined entity's strategy execution before making further investment decisions. The dilution for Semler shareholders and the control shift to Strive management are also key factors to monitor.

Keywords

Merger, Acquisition, Pro Forma Financials, Semler Scientific, Strive Inc, Bitcoin Treasury, All-Stock Transaction, SEC Filing, SMLR, ASST, Healthcare, Digital Assets